Place Your BETs in Combination Therapy
- PMID: 32559426
- DOI: 10.1016/j.molcel.2020.05.026
Place Your BETs in Combination Therapy
Abstract
Combination therapy remains the cornerstone for cancer management, and understanding how to rationally partner drugs is imperative. In this issue of Molecular Cell, Shu et al. (2020) provide a tour de force multi-omic approach to identify synergistic pathways that increase the efficacy of BET bromodomain inhibitors in triple-negative breast cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.
Comment on
-
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.Mol Cell. 2020 Jun 18;78(6):1096-1113.e8. doi: 10.1016/j.molcel.2020.04.027. Epub 2020 May 15. Mol Cell. 2020. PMID: 32416067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
